| Literature DB >> 35423213 |
Gayathri Pullangott1, Uthradevi Kannan1, Gayathri S1, Degala Venkata Kiran2, Shihabudheen M Maliyekkal1.
Abstract
The world has witnessed several incidents of epidemics and pandemics since the beginning of human existence. The gruesome effects of microbial threats create considerable repercussions on the healthcare systems. The continually evolving nature of causative viruses due to mutation or re-assortment sometimes makes existing medicines and vaccines inactive. As a rapid response to such outbreaks, much emphasis has been placed on personal protective equipment (PPE), especially face mask, to prevent infectious diseases from airborne pathogens. Wearing face masks in public reduce disease transmission and creates a sense of community solidarity in collectively fighting the pandemic. However, excessive use of single-use polymer-based face masks can pose a significant challenge to the environment and is increasingly evident in the ongoing COVID-19 pandemic. On the contrary, face masks with inherent antimicrobial properties can help in real-time deactivation of microorganisms enabling multiple-use and reduces secondary infections. Given the advantages, several efforts are made incorporating natural and synthetic antimicrobial agents (AMA) to produce face mask with enhanced safety, and the literature about such efforts are summarised. The review also discusses the literature concerning the current and future market potential and environmental impacts of face masks. Among the AMA tested, metal and metal-oxide based materials are more popular and relatively matured technology. However, the repeated use of such a face mask may pose a danger to the user and environment due to leaching/detachment of nanoparticles. So careful consideration is required to select AMA and their incorporation methods to reduce their leaching and environmental impacts. Also, systematic studies are required to establish short-term and long-term benefits. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35423213 PMCID: PMC8694960 DOI: 10.1039/d0ra10009a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361
Fig. 1Timeline of various deadly pandemics in history. This figure is adapted from the ref. 29 with modifications and the data is from the ref. 7, 20, 21, 24–26, 28 and 29.
Fig. 2Economic impact expressed as GDP loss (%).
Causative agents, hosts, mode of transmission, and reproductive number for the major viral diseases
| Causative virus | Transmitting hosts | Mode of transmission | Reproductive number |
|---|---|---|---|
| SARS coronavirus (SARS-CoV)[ | Bats, Civets | Respiratory droplets | 4 |
| MERS coronavirus (MERS-CoV)[ | Bats, Camels | Respiratory droplets, cough | 1 |
| Ebola[ | Nonhuman primates | Contact with body fluids | 1.5 to 2.5 |
| Seasonal Influenza (H3N2, H1N1)[ | Pig | Respiratory droplets | 2 |
| SARS-CoV-2 (ref. | Bats | Respiratory droplets | 1.5 to 3.5 |
Fig. 3(A) Particles filtration mechanisms in face masks; (B) face mask filter efficiency versus particle diameter. (B) is reproduced from the ref. 53 (open source subjected to creative common attribution 3.0 license).
Fig. 4Importance of wearing a face mask in healthcare settings.
Fig. 5Milestones in the evolution of face masks.
Fig. 6Various antimicrobial agents on face masks.
Fig. 7Overview of various antimicrobial agents employed in antimicrobial face masks.
Fig. 8(A) Dip coating; (B) melt-blowing; (C) electrospinning; this figure is adapted from the ref. 212 and 213 with modifications.
Fig. 9SEM images of fabrics incorporated with Chinese herb microcapsule: (A) cotton; (B) polyester; (C) nonwoven; this figure is reproduced from the ref. 120 (Gigvvy science open access publishing platform, subject to CC BY-SA 4.0 creative common attribution license).
Fig. 10SEM images: (A and B) first-layer; (C and D) second-layer; (E and F) third-layer of a commercial three-layered surgical mask coated with 1% GS5. (A), (C) and (E) have a magnification of 150×. White boxes in (A), (C), and (E) is magnified by 1000×, as shown in (B), (D), and (F). This figure is reproduced from ref. 100 with permission from Taylor & Francis, copyright 2016.
Fig. 11SEM image: (A and D) PMMA–DCDMH; (B and E) PMMA–DBDMH; (C and F) PMMA–DCDMH/DBDMH; TEM image: (G) PMMA–DCDMH; (H) PMMA–DBDMH; (I) PMMA–DCDMH/DBDMH nanofibres developed through electrospinning. This figure is reproduced from the ref. 229 with permission from American Chemical Society, copyright 2016.
Commercially available antimicrobial face masks
| Sl no. | Name of the product | Developed by | Antimicrobial agent/technology | Performance efficacy | Remarks |
|---|---|---|---|---|---|
| 1 |
| Sonovia (Israel) | Nano metal-oxide such as ZnO and CuO | • 1 log10 reduction of SARS-CoV-2 | • >98% particle filtration (5 μm) |
| • 6 log10 reduction of viruses similar to SARS-CoV-2 | • Reusable and potent up to 100 wash cycles at 70 °C | ||||
| • Less toxic to human and the environment | |||||
| • Pack of three costs 159 USD | |||||
| 2 |
| MedCu Technologies (Israel) | CuO | 4 log10 reduction of viruses within 30 min | • Pose no hazard upon disposal |
| • Conformitè Europëenne (CE) and FDA certified | |||||
| • Costs less than a conventional N95 face mask | |||||
| 3 |
| National Emergency Team of Israel and Israel Institute of Technology | Nanofibres coated with antiseptics | Blocks and neutralise viral particles | • This sticker can be attached to regular surgical face masks for the usage |
| 4 |
| Israel | Data not available | Viruses including SARS-CoV-2 | • Filters must be replaced every 12 h |
| • Wearable part can be washed and reused | |||||
| • Two filters and disposable envelopes cost 69 USD | |||||
| 5 |
| Gold Shield (China) | Organosilane based antimicrobial compound | 3 log10 reduction against bacteria and viruses like H1N1, methicillin-resistant | • Five-ply 3D N95 face mask |
| • Effective against particulates, pollutants, and pollens | |||||
| • US FDA approved | |||||
| • Reusable up to 14 days | |||||
| 7 |
| Good Research Solutions LLC (US) | Silver ions | 2 log10 reduction against pathogens | • Reusable cotton face mask |
| • 5-Layer activated carbon filter present | |||||
| • Potent up to 50 wash cycles | |||||
| 8 |
| Nexera medical Inc. (Canada) |
| • 4 log10 reduction of bacteria in 1 h | • Ag–Cu impounded to polyester fibres |
| • 5 log10 reduction of influenza viruses in 5 min | • Used up to 8 h continuously | ||||
| • NIOSH approved | |||||
| 9 |
| Copper Company (Chile) | Nano Cu | Antiviral activity against influenza viruses | • Three-layer nonwoven PP filter to embed nano-Cu |
| • Recyclable face mask made up of biocompatible polymer | |||||
| • Blocks 96.4% (1 μm) and 89.5% (0.02 μm) microorganisms | |||||
| 10 |
| Copper Compression (US) | Cu | Filters 99% of airborne particles equivalent to KN99 | • Four-layer washable and reusable face mask made up of cotton fabrics |
| • Durable up to 50 wash cycles | |||||
| • Costs 29.56 USD per piece | |||||
| 11 |
| Noveko International Inc (Canada) | Data not available | H1N1, H5N1, | • Complies with EN149:2001+A1:2009 standard |
| • BFE 99.8% | |||||
| • VFE 99.7% | |||||
| 12 |
| Fisher scientific (US) | Triosyn iodine-polymeric resin compound | 99.99% effective against airborne and droplet borne viruses | • Fluid resistance provides protection from blood, liquid splashes, and wet environmental contaminants |
| • Activated carbon layer combats organic vapours and odours | |||||
| 13 |
| Safe Life Corp (US) | Iodine | Data not available | • Compact, flat-fold design |
| • Was widely distributed by healthcare during Swine flu-2009 | |||||
| 14 |
| Nanosafe solutions and Indian Institute of Technology Delhi (India) | Data not available | Data not available | • Triple-layer filtration technology with antimicrobial layer |
| • BFE 99.2% | |||||
| • Complies with ASTM standard | |||||
| • Reuse potential up to 50 times | |||||
| 15 |
| ViralClyns (US) | Data not available | 95% effective against bacteria, viruses, spores, and protozoa | • Patented and EPA authorised antimicrobial agent |
| 16 |
| LIGC Applications (US) | Graphene and electrical charge | Data not available | • Electric charge repels particles deposited |
| • 99% effective against 0.3 μm particles | |||||
| 17 | Graphene-enhanced face mask[ | PlanarTECH & IDEATI's 2AM (UK) and Thailand | Graphene and other carbon nanomaterials | 99.95% effective against | • Reusable cotton face mask potent up to 10 cycles |
| • Repels the PM 2.5 dust | |||||
| • Costs 24.95 USD for a pack of three | |||||
| 18 |
| Redcliffe medical Devices Inc. (US) | Ultraviolet C (UVC) | 99.99% reduction of influenza A virus | • FDA cleared UVC N99 face mask |
| • HEPA and active carbon filters | |||||
| • 99.9997% filtration of 0.3 μm size |